Delivery Order SPE2DB22D2206-SPE2DB24FFK14
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,655.27 and an ultimate completion date of October 28, 2025. The contract involves no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a firm fixed price and a ceiling value of $16,027.08. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,515.96 firm-fixed-price contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the provision of pharmaceutical products and medical supplies. The contract has a ceiling value of $494,655.97 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is a for-profit organization that provides a wide range of pharmaceuticals and medical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,513.35 firm fixed-price contract has an ultimate completion date of January 13, 2025. Amerisourcebergen is a for-profit organization that specializes in distributing a wide range of pharmaceutical products, medical supplies, and equipment to federal healthcare programs, particularly those serving...
- This is a Delivery Order federal contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,659.34, is for the delivery of pharmaceutical products and medical supplies. It is a Firm Fixed Price contract with an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JADENU 360 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $11,586.33 and a completion date of May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,841.82 firm fixed-price contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFK14Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple DLA contracts. This includes an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/31/24 |